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postoperative analgesia with regard to
preventing chronic or neuropathic
pain after thoracotomy
Sandra Kampe1*, Joachim Lohmer2†, Gerhard Weinreich3†, Moritz Hahn4†, Georgios Stamatis5† and Stefan Welter5†Abstract
Background: To assess prospectively the incidence of chronic and neuropathic pain in patients undergoing
anteroaxillary thoracotomy with postoperative epidural analgesia or controlled-release oxycodone pain regimen.
Methods: 77 patients who underwent anteroaxillary thoracotomy were enrolled in our observational study. 40
patients received postoperatively a standardized oral analgesic protocol with controlled-release oxycodone and IV
non opioid (CRO Group), and 37 patients received epidural analgesia with ropivacaine 0.1% + 1 μg/ml sufentanil
(EDA Group) and IV non opioid. The painDETECT questionnaire was completed from the patients with one of the
authors (JL) on the 7th postoperative day and six months postoperatively.
Results: The data of 60 patients were eligible for statistical analysis, 28 patients in the CRO Group and 32 patients
in the EDA Group. 17 patients did not reach the 6-months follow-up interval (12 drop outs in the CRO Group and 5
drop outs in the EDA Group). 79% percent of patients in the CRO Group and 74% percent of patients in the EDA
Group had a numeric rating scale score (NRS) = 0 after 6 months. 22% percent of patients in the CRO Group and
16% percent of patients in the EDA Group experienced a NRS 1–3 6-months postoperatively. No patient in the CRO
Group and 9% percent of patients in the EDA Group had 6-months postoperatively a NRS 4–6. Neither in the CRO
Group nor in the EDA Group we could detect a neuropathic pain 6 months postoperatively corresponding to a
painDETECT score > 18. Overall, with regard to NRS, there was no statistical difference between the two groups
(p = 0.13). 90% percent of patients in the CRO Group and 90% percent of patients in the EDA Group showed
6-months postoperatively a painDETECT score < 13 (definitely no neuropathic pain), and 9% percent in the EDA
Group and 11% in the CRO Group had a 6-months painDETECt score 13–18 (p = not significant).
Conclusion: These pilot data indicate that epidural analgesia is not superior to systemic postoperative analgesia
with regard to preventing chronic or neuropathic pain after thoracotomy.Background
Pain after thoracic surgery is supposed to be one of the
most recognized pain syndrome associated with a spe-
cific procedure [1]. Reports indicated that 50% of pa-
tients describe a chronic postthoracotomy pain (CPP)
one year after the procedure [2], more recent data* Correspondence: Sandra.kampe@ruhrlandklinik.uk-essen.de
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reproduction in any medium, provided the orsuggest that CPP might appear in 21% of patients one
year after surgery when perioperative pain is managed
aggressively [1].
To date regional anaesthesia is recommended for post-
operative analgesia after thoracotomy [1,3,4]. Therefore
published data on the incidence of CPP are commonly
based on postoperative analgesia with regional tech-
niques [5-7]. To our knowledge to date there are no pro-
spective data available with regard on the incidence of
CPP and neuropathic pain after thoracotomy with epi-
dural analgesia (EDA) compared to a systemic pain regi-
men with controlled-release oxycodone (CRO).Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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spectively the incidence of chronic and neuropathic pain
in patients undergoing anteroaxillary thoracotomy with
postoperative epidural analgesia or controlled-release
oxycodone pain regimen over a 6-months period.
Methods
After obtaining local research committee approval
(Ethics Committee of the University of Essen-Duisburg)
and written informed consent, 77 patients were enrolled
in our prospective observational study, conducted
according to the Declaration of Helsinki.
Eligible patients were those scheduled for thoracot-
omy, aged 18–70 years and American Society of Anes-
thesiologists (ASA) physical status I-IV. Patients were
not randomly assigned to one or the other observation
group, the determination of the postoperative analgesic
regimen was due to the discretion of the anaesthetist
performing the preoperative interview with the patient.
One of the authors (JL) included the patients into the study
on the 2nd postoperative day. Patients with a preoperative
pain history (numeric rating scale score NRS > 0) were not
included. Further exclusion criteria were communication
difficulties, psychiatric disease, pregnancy and a history of
drug or alcohol abuse.
All patients underwent anteroaxillary thoracotomy
in balanced anaesthesia. If an epidural catheter was
inserted, it was placed before induction of anaesthesia
and commenced after start of surgery continuously at
4–6 ml/h.
Half an hour before the end of the surgical procedure
all patients received 2.5 g of IV dipyrone. Dipyrone is a
non-opioid analgesic frequently used in the perioperative
setting in Germany. After extubating the trachea patients
received IV piritramide at the discretion of the anaesthe-
tist. Piritramide is an opioid commonly used in Germany
with approximately 0.7 times the potency of morphine.
Patients were admitted to the intensive care unit for one
night and received 1 g of dipyrone every 6 hours and IV
piritramide bolus doses when NRS (numeric rating scale,
0 = no pain up to 10 = worst pain imaginable) was > 3. If
patients had epidurals, the EDA was continued.
After discharge from the intensive care unit on the first
postoperative day (POD) the systemic pain therapy patients
received controlled-release oxycodone (CRO Group) 30–0
– 20 mg, and from the 2nd POD 20 – 0–20 mg and IV
dipyrone 1 g every 6 h. If the NRS was > 4 IV rescue medi-
cation with IV paracetamol was administered (up to
15 mg/kg). The EDA Group received postoperatively epi-
dural analgesia with ropivacaine 0.1% + 1 μg/ml sufentanil
(EDA Group) and IV dipyrone 1 g every 6 h. On the fourth
POD IV dipyrone 1 g was oralized.
All patients received anteroaxillary thoracotomy via
the 4th intercostal space. The serratus muscle was notcut, but spread. At the end of surgery two 24 CH soft
chest tubes were placed and the thoracic cavum was
closed with three pericostal sutures.
During their stay in hospital all patients were visited
daily by an anaesthetist specialized in pain therapy and
pain medication was adjusted to the state of recovery.
Moreover NRS at rest and on coughing were documented
by the nurses on the wards every 6 h, implicating that the
rescue medication had to be administered by the nurse
when NRS scores > 3 at rest and > 5 on coughing. Thirty
min after administration of rescue medication the NRS
had to be re-assessed. If pain score was again > 5 on
coughing, the nurse had to contact the anaesthetist re-
sponsible for postoperative pain therapy.
The painDETECT questionnaire was completed from
the patients with one of the authors (JL) twice during
the study period: on the 7th POD and 6-months
postoperatively.
The painDETECT questionnaire was originally designed
from the German Research network on Neuropathic Pain
(Deutscher Forschungsverbund Neuropathischer Schmerz,
DFNS) to find out how neuropathic pain symptoms are
perceived by the patients. As a result, 7 questions that
address the quality of neuropathic pain symptoms were
included in the questionnaire (Table 1). Patients` an-
swers were to be multiplicated with different multiplica-
tion factors generating a total score between 0–38. A
total score from 0–12 assesses a neuropathic compo-
nent to be very unlikely, a total score of 13–18 impli-
cates that a neuropathic component might be possible,
and a score between 19–38 confirms a neuropathic
component.
All variables were analyzed by methods of descriptive
statistics (frequency, mean ± standard deviation, range).
Differences between groups were analyzed by using the
Mann–Whitney-U test and differences in proportions
were statistically evaluated by using chi2 test. Statistical
significance was determined at the p < 0.05 level.
Statistical analysis was performed by using SPSS 20.0
statistical package.
Results
In 2008–2010,77 patients were enrolled in our study. The
data of 60 patients were eligible for statistical analysis, 28
patients in the CRO Group and 32 patients in the EDA
Group. 17 patients did not reach the 6-months follow-up
interval (12 drop outs in the CRO Group and 5 drop outs
in the EDA Group). The time of the surgical procedure
was 147 ± 45 min in the CRO Group and 173 ± 59 min in
the EDA Group (p = 0.08). The surgical procedures are
presented in Table 2. In the CRO Group there were 9
females, in the EDA Group 5 female patients. 11 patients
in the CRO Group were ASA II and 17 patients ASA III
classified, in the EDA Group 6 patients were ASA II and




Do you suffer from a burning sensation (e.g. stinging ncttksj in the marked areas?
• Do you have a tingling or prickling sensation in the area of your pain (like crawling ants or electrical
tingling)?
0-5
• Is hght touching (clothing, a blanket) in this area painful? 0-5
• Do you have sudden pain attacks in the area of your pain, like electric chcks 0-5
• Is cold or heat (bath water) in this area occasionally painful? 0-5
• Do you suffer trom a sensation of numbness in the areas that you marked? 0-5
• Does slight pressure in this area, e.g. with a finger, trigger pain? 0-5
Pain course pattern
-1
Please select the picture that best describes the course of your pain:
+1
Persistent pain with slight fluctuations
Persistent pain with pain attacks
Pain attacks without pain between them
Pain attacks with pain between them
Radiating pain
+1
Does your pain radiate to other regions of your body? Yes/No +2/0
For each question: never, 0; hardly noticed. I slightly. 2; moderately. 3: strongly, 4; very strongly, 5 Questions used to document pain, but which were not used in
the scoring, are not shown.
Cited from CMRO 2008;22 [10]:1911–20.
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NRS score 6-months postoperatively are presented in
Table 3. 79% percent of patients in the CRO Group and
74% percent of patients in the EDA Group had a numeric
rating scale score (NRS) = 0 after 6 months. 22% percent
of patients in the CRO Group and 16% percent of patients
in the EDA Group experienced a NRS 1–3 6-monthsTable 2 Surgical procedures
Surgical procedures CRO Group EDA Group
n = 28 n = 32
Lobectomy 20 20
Pneumonectomy 3 6
Wedge resection 1 1
Segmentectomy 4 4
Others 1
N, Number of patients; EDA, Epidural Group; CRO, Controlled-release
oxycodone Group.postoperatively. No patient in the CRO Group and 9%
percent of patients in the EDA Group had 6-months post-
operatively a NRS 4–6. Overall, with regard to NRS, there
was no statistical difference between the two groups (p =
0.13). The painDETECT scores 7-days and 3-months post-
operatively are presented in Table 4. Neither in the CROTable 3 Percentages of patients with their NRS scores
6-months postoperatively in both groups
NRS CRO Group EDA Group p
n = 28 n = 32
NRS 0 79% 74% n.s.
NRS 1-3 22% 16% n.s.
NRS 4-6 0% 9% n.s.
NRS 7-10 0% 0% n.s.
CRO Group, Systemic pain therapy group; EDA Group, Epidural analgesia group;
n, Number of patients, NRS (numeric rating scale from 0 = no pain to 10 =
worst pain imaginable) preoperatively, 6-months postoperatively.
Table 4 Percentages of patients with their painDETCET
score 7-days postoperatively and 6-months postoperatively
PainDETECT
score
7-days postop. 6-months postop.
n n
EDA CRO EDA CRO
0-12 90% 83% 90% 90%
13-18 3% 14% 9% 11%
> 19 3% 0% 0% 0%
N, Number of patients; EDA, Epidural Group; CRO, Controlled-release
oxycodone Group.
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neuropathic pain 6 months postoperatively corresponding
to a painDETECT score > 18. 90% percent of patients in
the CRO Group and 90% percent of patients in the EDA
Group showed 6-months postoperatively a painDETECT
score < 13 (definitely no neuropathic pain), and 9% percent
in the EDA Group and 11% in the CRO Group had a 6-
months painDETECt score 13–18 (p = not significant).
Discussion
Recently published data suggest that CPP might appear
in around 20% of patients after thoracotomy when post-
operative pain is managed aggressively [1]. These good
results are based on postoperative analgesia via the epi-
dural route. To date the “gold standard” for postopera-
tive analgesia after thoracic surgery are regional
techniques [1,3,4]. To our knowledge there are no pro-
spective results available on the incidence of CPP after
aggressive systemic pain therapy with controlled-release
opioids compared to epidural analgesia. The objective of
our prospective study was to assess the incidence and
quality of CPP in patients undergoing elective thoracic
surgery with postoperative epidural analgesia versus
controlled-release oxycodone pain regimen over a 6-
months period. We found no patient (zero percent) with
a neuropathic pain 6 months postoperatively.
Steegers et al. determined definite neuropathic pain to
be present in 23% of the patients with CPP [8] also by
using the painDETECT questionnaire, the same tool for
detecting neuropathic pain. Steegers et al. performed the
study retrospectively and the patients were treated with
posterolateral thoracotomy. Therefore data are not com-
parable to ours examined in anteroaxillary thoracotomy
patients. Maguire et al. recently reported the prevalence
of neuropathic pain between 35-83% after thoracotomy
[5]. The authors could generate data of 600 patients with
thoracotomy over 7 past years, but neither the proced-
ure e.g. the anaesthetic management, nor the pain man-
agement was standardized. Moreover the surgical
management was not standardized, different staff is de-
scribed, various sizes of chest drains are reported [5].Finally again, data are not comparable to our design as
all patients in this study underwent a posterolateral
thoracotomy. Guastella et al. demonstrated an incidence
of neuropathic pain at 29% after lateral or posterolateral
thoracotomy [9]. Data were assessed prospectively, but
cannot be compared to our data as the presence of CPP
was inclusion criteria for this study.
In our hospital pericostal sutures are common practice
and our good results underline the atraumatic approach
and closure of our surgeons. Cerfolio et al. stated that
intracostal sutures decrease the pain after thoracotomy,
but they present only mean pain scores after 2 weeks until
three months postoperatively, but no incidences or per-
centages of patients who develop CPP [10]. All patients
underwent a posterolateral thoracotomy with epidural an-
algesia in this retrospective study, we, therefore, cannot
compare these results to ours. Our patients underwent an
anteroaxillary surgical approach, the standard approach in
our thoracic hospital. Little is known about the impact of
the surgical approach on the incidence of CPP. Nasotti
et al. compared a muscle sparing approach versus postero-
lateral thoracotomy for pulmonary lobectomy and found
no difference in postoperative pain results and incidence
of postthoracotomy pain syndrome [11]. Recently pub-
lished data focus for the first time on the effect of the sur-
gical access and wound closure on postoperative pain [12].
According to Sakakura et al. patients after posterolateral
thoracotomy experienced more pain than anteroaxillary
thoracotomy patients. These data cannot be compared to
our data, as they fail to describe incidences of CPP and
neuropathic component, but describe mean pain scores
within the groups. However, our study was not designed
to answer the question if the surgical approach influences
patients`outcome with regard to chronic pain.
The painDETECT questionnaire is classified as validated
tool for assessing neuropathic pain [8,13]. However, the
painDETECT questionnaire might have limitations in
detecting CPP. Moreover, functional exploration would
have increased the impact of our data [14].
Our pilot data indicate that postoperative epidural an-
algesia might not be superior to systemic oral analgesia
with regard to establishing CPP. More RCT`s with a
greater number of patients and postoperative functional
exploration are necessary to investigate if consequent
systemic pain regimen and postoperative epidural anal-
gesia are equally effective in preventing CPP.
Limitations of the study
One limitation of our study is that the study was not
randomized and double-blinded. The investigator (JL)
might have been biased.
Another limitation is the different number of drop
outs in both groups. Therefore, there might be a bias in
the results and in interpreting the results.
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These pilot data indicate that epidural analgesia is not su-
perior to sytemic postoperative analgesia with regard to
preventing chronic or neuropathic pain after thoracotomy.
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